About this event

  • Date and time Wed 20 Nov 2019 from 8:45am to 4:00pm
  • Location Royal Society of Medicine
  • Organised by Gastroenterology and Hepatology

The RSM liver day will explore key advances in our understanding and management of liver disease. Plus a comprehensive review across a wide range of key hepatological conditions.

The meeting will provide a unique forum for consultant hepatologists, gastroenterologists, specialist registrars and clinical nurse specialists to discuss the current challenges and approaches to the management of liver disease.

You will learn:

  • The latest therapeutic advances in chronic liver disease
  • How to optimise outcome in alcohol-related liver disease
  • The latest therapeutic strategies for viral hepatitis
  • Optimise management in acute liver failure and the criteria for transplantation
  • Review the pathogenesis and management strategy for fatty liver disease

We would like to thank our sponsor(s):
Bayer and Intercept UK & Ireland Ltd
Each of these sponsor(s) has supported this educational meeting through a payment to exhibit with a stand. Please note that none of the companies listed above have had any influence or involvement over the agenda, content or organisation of this meeting.

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction

Session One

Chair: Introduction

Professor Patrick Kennedy, Honorary Consultant Hepatologist, Barts and the London School of Medicine and Dentistry, Queen Mary University of London

Hepatology through the crystal ball

Professor Roger Williams, Consultant Hepatologist, King’s College London

Alcoholic liver disease

Mr Paul Richardson, Consultant Hepatologist, Royal Liverpool NHS Trust

Tea and coffee break
Decompensated liver disease

Dr Alistair O’Brien, Consultant Hepatologist, University College London Hospitals NHS Foundation Trust

NASH

Dr Will Alazawi, Consultant Hepatologist, Barts Health NHS Trust

Lunch

Session two

Chair: Introduction

Professor Patrick Kennedy

Radiological evaluation of the liver, liver reserve pre-surgery and the role of PVE

Dr Dominic Yu, Consultant Radiologist, Royal Free London NHS Foundation Trust

Latest management of cholestatic liver disease

Dr Yiannis Kallis, Consultant Hepatologist, Barts Health NHS Trust

The assessment of liver reserve in cirrhotic and non-cirrhotic patients pre-operatively and post-operative care

Dr Mark McPhail, Senior Lecturer and Consultant in Liver Critical Care in the Institute of Liver Studies, King's College London

New treatments in HBV and HDV

Dr Upkar Gill, NIHR Academic Clinical Lecturer and Honorary Hepatology Registrar, Barts Liver Centre, Centre for Immunobiology, Barts and The London School of Medicine & Dentistry, Queen Mary University of London

Questions and answers
Concluding remarks
Close of meeting

Sponsors

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom